Connect with us

Hi, what are you looking for?

Jewish Business News

Syndicated

PathXL becomes Global Reseller of Indica Labs’ Image Analysis Software

PathXL today announced a global partnership with Indica Labs to resell HALO, their next generation image analysis platform.

PathXL today announced a global partnership with Indica Labs to resell HALO, their next generation image analysis platform.

Online PR News – 10-July-2014HALO was designed by Indica Labs to be the fastest, most scalable, user-friendly image analysis software for digital pathology applications. By reselling HALO suite, PathXL will further extend its ability to serve the broadest needs of the market.

The platform features Indicas large portfolio of morphometric and colorimetric analysis tools for neuroscience, metabolism, oncology, and toxicological pathology. HALO provides cell-by-cell results, making it ideally suited for quantification of cell-based immunohistochemistry, immunofluorescence and in situ hybridization (ISH) assays.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.

Analysis can be performed across large studies of whole slide images or on single field-of-view images, and HALOs modular design supports both affordable, small-scale, desktop environments and high-throughput, multi-node, networked environments.

“Image analysis is a key requirement for todays advanced Digital Pathology systems, ” says Des Speed, CEO of PathXL. “We see great synergy between Indica Labs extensive portfolio of image analysis algorithms and PathXLs focus on top quality products for the digital pathology lab. The HALO platform together with the Indica algorithms will further deepen PathXLs commitment to excellence in tumor analysis and in the delivery of next generation solutions for the Pathologist.”

Steven Hashagen, Indica CEO added, “We are excited about this new partnership with PathXL which will help to drive the continued adoption of our HALO image analysis platform. PathXL has a successful history of delivering advanced solutions for digital pathology and a deep understanding of customer needs in this market. PathXLs scanner agnostic approach fits well with our own focus on providing advanced image analysis solutions to every part of the market.”

About PathXL Ltd
PathXL is a global pioneer in the use of web-based solutions for digital pathology and provides innovative software for use in research, clinical and education applications worldwide. The company focuses specifically on the oncology sector aiming to provide expertise and excellence in tumor analysis. PathXLs award winning product, TissueMark, assists the Pathologist with an automated analysis of tumor boundary and % tumor content across a range of tumor types, greatly reducing errors due to the natural variability in human assessment.

For more information on HALO from PathXL, please visit http://www.pathxl.com/image-analysis/pathxl-with-halo or contact sales@pathxl.com.

About Indica Labs, Inc.
Indica Labs provides software for quantitative evaluation of pathology images. Indicas HALO image analysis platform provides a unique combination of precision, performance, scalability, and usability. Indicas broad range of industry leading tissue-specific image analysis algorithms can be used in a variety of truly integrated digital pathology environments, allowing pharmaceutical, healthcare, and research organizations worldwide to apply high-throughput image quantification in areas such as neuroscience, metabolism, oncology, toxicological pathology, and more. For more information, please visit http://indicalab.com or contact info@indicalab.com

Quote:

“The HALO platform together with the Indica algorithms will further deepen PathXLs commitment to excellence in tumor analysis and in the delivery of next generation solutions for the Pathologist.”

Company Contact Information
John Durborow – Sales and Business Development Director, North America
http://www.pathxl.com/
410.921.6974
 

Newsletter



Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Entertainment

The Movie The Professional is what made Natalie Portman a Lolita.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.

Copyright © 2021 Jewish Business News